ID: ALA3623681

Max Phase: Preclinical

Molecular Formula: C20H23BrN2O4

Molecular Weight: 354.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Br.O=[N+]([O-])c1ccc(-c2ccc(C3(O)CN4CCCCC4CO3)cc2)cc1

Standard InChI:  InChI=1S/C20H22N2O4.BrH/c23-20(14-21-12-2-1-3-19(21)13-26-20)17-8-4-15(5-9-17)16-6-10-18(11-7-16)22(24)25;/h4-11,19,23H,1-3,12-14H2;1H

Standard InChI Key:  ASFIOIICAFOYPH-UHFFFAOYSA-N

Associated Targets(non-human)

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Squalene synthetase 891 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver 4264 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 354.41Molecular Weight (Monoisotopic): 354.1580AlogP: 3.29#Rotatable Bonds: 3
Polar Surface Area: 75.84Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.95CX Basic pKa: 6.93CX LogP: 4.06CX LogD: 3.94
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.68Np Likeness Score: -0.13

References

1. Ladopoulou EM, Matralis AN, Nikitakis A, Kourounakis AP..  (2015)  Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution.,  23  (21): [PMID:26433631] [10.1016/j.bmc.2015.09.034]

Source